J&J U.S. PHARMACEUTICAL SALES CLIMB 15.6% TO $496 MIL. IN FIRST QUARTER; SCHERING CLARITIN SALES ARE $130 MIL. IN FIRST NINE MONTHS ON U.S. MARKET

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".